ResMed Inc (RMD)
217.00
+33.58
(+18.31%)
USD |
NYSE |
Apr 26, 13:21
ResMed Free Cash Flow: 943.73M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | 943.73M |
| September 30, 2023 | 792.43M |
| June 30, 2023 | 559.30M |
| March 31, 2023 | 407.69M |
| December 31, 2022 | 221.63M |
| September 30, 2022 | 304.85M |
| June 30, 2022 | 195.11M |
| March 31, 2022 | 343.67M |
| December 31, 2021 | 445.52M |
| September 30, 2021 | 397.18M |
| June 30, 2021 | 619.89M |
| March 31, 2021 | 733.32M |
| December 31, 2020 | 773.77M |
| September 30, 2020 | 683.96M |
| June 30, 2020 | 696.32M |
| March 31, 2020 | 504.78M |
| December 31, 2019 | 419.84M |
| September 30, 2019 | 486.82M |
| June 30, 2019 | 381.71M |
| March 31, 2019 | 373.83M |
| December 31, 2018 | 385.18M |
| September 30, 2018 | 390.37M |
| June 30, 2018 | 433.57M |
| March 31, 2018 | 443.58M |
| December 31, 2017 | 360.20M |
| Date | Value |
|---|---|
| September 30, 2017 | 349.08M |
| June 30, 2017 | 342.58M |
| March 31, 2017 | 349.06M |
| December 31, 2016 | 408.01M |
| September 30, 2016 | 443.53M |
| June 30, 2016 | 480.10M |
| March 31, 2016 | 439.08M |
| December 31, 2015 | 407.57M |
| September 30, 2015 | 353.53M |
| June 30, 2015 | 311.24M |
| March 31, 2015 | 320.43M |
| December 31, 2014 | 323.34M |
| September 30, 2014 | 301.61M |
| June 30, 2014 | 310.11M |
| March 31, 2014 | 321.35M |
| December 31, 2013 | 326.40M |
| September 30, 2013 | 339.65M |
| June 30, 2013 | 331.04M |
| March 31, 2013 | 308.92M |
| December 31, 2012 | 297.33M |
| September 30, 2012 | 317.48M |
| June 30, 2012 | 322.05M |
| March 31, 2012 | 294.05M |
| December 31, 2011 | 284.74M |
| September 30, 2011 | 235.76M |
Free Cash Flow Range, Past 5 Years
195.11M
Minimum
Jun 2022
943.73M
Maximum
Dec 2023
521.66M
Average
486.82M
Median
Sep 2019
Free Cash Flow Benchmarks
| Stryker Corp | 3.136B |
| Boston Scientific Corp | 1.703B |
| Integer Holdings Corp | 60.28M |
| Haemonetics Corp | 128.75M |
| Insulet Corp | 36.50M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 272.83M |
| Cash from Investing (Quarterly) | -41.14M |
| Cash from Financing (Quarterly) | -238.96M |
| Free Cash Flow Per Share (Quarterly) | 1.683 |
| Free Cash Flow to Equity (Quarterly) | 383.02M |
| Free Cash Flow to Firm (Quarterly) | 259.38M |
| Free Cash Flow Yield | 2.95% |